Fortress Biotech Inc.

04/01/2021 | Press release | Distributed by Public on 04/01/2021 05:06

Journey Medical Corporation Enters into a Definitive Agreement with Dermira, Inc., a Wholly-Owned Subsidiary of Eli Lilly and Company, to Acquire QBREXZA®